167 related articles for article (PubMed ID: 12787399)
1. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.
Zhou A; Ueno H; Shimomura M; Tanaka R; Shirakawa T; Nakamura H; Matsuo M; Iijima K
Kidney Int; 2003 Jul; 64(1):92-101. PubMed ID: 12787399
[TBL] [Abstract][Full Text] [Related]
2. Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis.
Sakamoto T; Ueno H; Sonoda K; Hisatomi T; Shimizu K; Ohashi H; Inomata H
Gene Ther; 2000 Nov; 7(22):1915-24. PubMed ID: 11127579
[TBL] [Abstract][Full Text] [Related]
3. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
[TBL] [Abstract][Full Text] [Related]
4. Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule.
Haviv YS; Takayama K; Nagi PA; Tousson A; Cook W; Wang M; Lam JT; Naito S; Lei X; Carey DE; Curiel DT
J Gene Med; 2003 Oct; 5(10):839-851. PubMed ID: 14533192
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
[TBL] [Abstract][Full Text] [Related]
6. Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats.
Fujigaki Y; Sun DF; Fujimoto T; Yonemura K; Morioka T; Yaoita E; Hishida A
Virchows Arch; 2001 Jul; 439(1):35-45. PubMed ID: 11499838
[TBL] [Abstract][Full Text] [Related]
7. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
8. Immunoelectron microscopic study on type I, II and III TGF-beta receptors on visceral glomerular epithelial cells in relation to glomerular basement membrane alterations in proteinuric rats.
Fujigaki Y; Watanabe T; Ikegaya N; Yonemura K; Sun DF; Hishida A; Yamamoto T; Kojima K; Nagase M
Nephrol Dial Transplant; 2000 Feb; 15(2):191-9. PubMed ID: 10648664
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of glomerular inflammatory cells and expression of adhesion molecules in anti-glomerular basement membrane (anti-GBM) glomerulonephritis induced in WKY rats with monoclonal anti-GBM antibodies of different subclasses.
Kado T; Kohda T; Okada S; Hayashi A; Utsunomiya Y; Kanzaki S; Sado Y; Yamamoto T
Pathol Int; 2006 Feb; 56(2):55-61. PubMed ID: 16445816
[TBL] [Abstract][Full Text] [Related]
11. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
[TBL] [Abstract][Full Text] [Related]
12. LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease.
Tesch GH; Hill PA; Wei M; Nikolic-Paterson DJ; Dutartre P; Atkins RC
Kidney Int; 2001 Oct; 60(4):1354-65. PubMed ID: 11576349
[TBL] [Abstract][Full Text] [Related]
13. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
14. Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.
Chung IM; Kim J; Pak YK; Jang Y; Yang WI; Han I; Park SJ; Park SW; Huh J; Wight TN; Ueno H
Int J Cardiol; 2010 Dec; 145(3):468-75. PubMed ID: 20053468
[TBL] [Abstract][Full Text] [Related]
15. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
[TBL] [Abstract][Full Text] [Related]
16. Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein.
Xin J; Homma T; Matsusaka T; Ma J; Isaka Y; Imai E; Ichikawa I
Transplantation; 2004 May; 77(9):1433-42. PubMed ID: 15167603
[TBL] [Abstract][Full Text] [Related]
17. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis.
Iyoda M; Shibata T; Wada Y; Kuno Y; Shindo-Hirai Y; Matsumoto K; Akizawa T
Nephrol Dial Transplant; 2013 Mar; 28(3):576-84. PubMed ID: 23045430
[TBL] [Abstract][Full Text] [Related]
18. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats.
Ueno H; Sakamoto T; Nakamura T; Qi Z; Astuchi N; Takeshita A; Shimizu K; Ohashi H
Hum Gene Ther; 2000 Jan; 11(1):33-42. PubMed ID: 10646637
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice.
Nagashio Y; Ueno H; Imamura M; Asaumi H; Watanabe S; Yamaguchi T; Taguchi M; Tashiro M; Otsuki M
Lab Invest; 2004 Dec; 84(12):1610-8. PubMed ID: 15502860
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
